These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16574028)

  • 21. Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
    Greenfield SF; Azzone V; Huskamp H; Cuffel B; Croghan T; Goldman W; Frank RG
    J Subst Abuse Treat; 2004 Dec; 27(4):265-75. PubMed ID: 15610828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey.
    McIntyre RS; Konarski JZ; Wilkins K; Bouffard B; Soczynska JK; Kennedy SH
    Headache; 2006 Jun; 46(6):973-82. PubMed ID: 16732843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absenteeism and health-benefit costs among employees with MS.
    Brook RA; Rajagopalan K; Kleinman NL; Melkonian AK
    Curr Med Res Opin; 2009 Jun; 25(6):1469-76. PubMed ID: 19422277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.
    Gonzalez-Pinto AM; Dardennes R; de Zélicourt M; López P; Oliveros RG; Vieta E; Barbeito S; Echevarria E; Fagnani F
    J Affect Disord; 2010 Feb; 121(1-2):152-5. PubMed ID: 19482360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional dyspepsia impacts absenteeism and direct and indirect costs.
    Brook RA; Kleinman NL; Choung RS; Melkonian AK; Smeeding JE; Talley NJ
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):498-503. PubMed ID: 20304102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
    McCombs JS; Ahn J; Tencer T; Shi L
    J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
    Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Wolfe F
    J Rheumatol; 2004 Aug; 31(8):1621-9. PubMed ID: 15290744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bipolar disorder not otherwise specified in relation to the bipolar spectrum.
    Bader CD; Dunner DL
    Bipolar Disord; 2007 Dec; 9(8):860-7. PubMed ID: 18076535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.
    Carney CP; Jones LE
    Psychosom Med; 2006; 68(5):684-91. PubMed ID: 17012521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental health care utilization and costs in a corporate setting.
    Tsai SP; Bernacki EJ; Reedy SM
    J Occup Med; 1987 Oct; 29(10):812-6. PubMed ID: 3681492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct medical costs unique to people with arthritis.
    Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
    J Rheumatol; 1997 Apr; 24(4):719-25. PubMed ID: 9101508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.